The Vanguard Group's Stake in Mural Oncology plc

The Vanguard Group, Inc. has disclosed its stake in Mural Oncology plc through an Opening Position Disclosure. The disclosure, required under Rule 8.3 of the Irish Takeover Panel Act 1997, pertains to relevant securities encompassing 1% or more.

As of April 29, 2025, Vanguard holds 772,687 ordinary shares in Mural Oncology, representing 4.47% of the company's total securities. Additionally, a recent transaction involved the purchase of 90 shares at $2.62 per share. The disclosure indicates no involvement in other forms of security dealings, such as derivatives or options, by Vanguard in relation to Mural Oncology.

No indemnity or option arrangements, nor agreements on security dealings, were reported by Vanguard in this disclosure. There is no supplemental information attached to the current filing.